Literature DB >> 1760939

Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins.

M Gehrlein1, H Leying, W Cullmann, S Wendt, W Opferkuch.   

Abstract

The comparison of a clinical Acinetobacter baumanii isolate (strain No. 4852/88) and its selected imipenem-resistant (IMR) clone exhibited a complex reorganization of the penicillin-binding proteins (PBPs) with diminished labelling of all PBPs except the 24-kD PBP which showed an increased binding of 14C-penicillin. This protein could not be saturated by preincubation of membranes with imipenem at 8-fold the MIC of imipenem, thus indicating PBP alterations responsible for imipenem resistance. In A. baumanii 4852/88 seven PBPs with the apparent molecular weights of 94, 84, 65, 61, 48, 40 and 24 kD could be detected. beta-Lactamase production was barely detectable in any case and could not be enhanced in the presence of various beta-lactams as the inducer. The outer membrane proteins were found identical in both the wild-type strain and the Im clone. So far, imipenem-resistant A. baumanii isolates have been isolated twice in our diagnostic laboratory; however, no implications on the future relevance of the above findings can be made.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1760939     DOI: 10.1159/000238887

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  48 in total

1.  Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.

Authors:  G J Da Silva; G J Leitão; L Peixe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii.

Authors:  Axel Siroy; Virginie Molle; Christelle Lemaître-Guillier; David Vallenet; Martine Pestel-Caron; Alain J Cozzone; Thierry Jouenne; Emmanuelle Dé
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Types and prevalence of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in Northern Taiwan.

Authors:  Wen-Shyang Hsieh; Nai-Yu Wang; Jou-An Feng; Li-Chuan Weng; Hsueh-Hsia Wu
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

7.  Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii.

Authors:  Maria del Mar Tomás; Alejandro Beceiro; Astrid Pérez; David Velasco; Rita Moure; Rosa Villanueva; Jesús Martínez-Beltrán; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

8.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

9.  Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.

Authors:  S López-Hernández; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.

Authors:  Krisztina M Papp-Wallace; Baui Senkfor; Julian Gatta; Weirui Chai; Magdalena A Taracila; Veerabahu Shanmugasundaram; Seungil Han; Richard P Zaniewski; Brian M Lacey; Andrew P Tomaras; Marion J Skalweit; Michael E Harris; Louis B Rice; John D Buynak; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.